Cargando…

Insulin-like Growth Factor 1 (IGF1), IGF Binding Protein-3 (IGFBP3) and Growth Response to Daily Zinc Supplementation: A Randomized Trial in Rural Laotian Children

Objectives: To assess (a) the impact of daily preventive zinc tablets (7 mg; PZ), zinc-containing multiple micronutrient powder (10 mg zinc, and 13 other micronutrients; MNP) or placebo, delivered for 9 months, on Insulin-like Growth Factor 1 (IGF1) and IGF Binding Protein 3 (IGFBP3) among Laotian c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barffour, Maxwell A., Bernstein, Robin M., Hinnouho, Guy-Marino, Wessells, K. Ryan, Arnold, Charles D., Kounnavong, Sengchanh, Hess, Sonja Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10255720/ https://www.ncbi.nlm.nih.gov/pubmed/37299552 http://dx.doi.org/10.3390/nu15112590

Ejemplares similares

Impact of Two Forms of Daily Preventive Zinc or Therapeutic Zinc Supplementation for Diarrhea on Hair Cortisol Concentrations Among Rural Laotian Children: A Randomized Controlled Trial
por: Hinnouho, Guy-Marino, et al.
Publicado: (2018)

Effects of Daily Zinc, Daily Multiple Micronutrient Powder, or Therapeutic Zinc Supplementation for Diarrhea Prevention on Physical Growth, Anemia, and Micronutrient Status in Rural Laotian Children: A Randomized Controlled Trial
por: Barffour, Maxwell A., et al.
Publicado: (2019)

Impact of Different Strategies for Delivering Supplemental Zinc on Selected Fecal Markers of Environmental Enteric Dysfunction among Young Laotian Children: A Randomized Controlled Trial
por: Hinnouho, Guy-Marino, et al.
Publicado: (2020)

Comparison of haemoglobin assessments by HemoCue and two automated haematology analysers in young Laotian children
por: Hinnouho, Guy-Marino, et al.
Publicado: (2018)

Impact of Daily Preventive Zinc or Therapeutic Zinc Supplementation for Diarrhea on Plasma Biomarkers of Environmental Enteric Dysfunction among Rural Laotian Children: A Randomized Controlled Trial
por: Wessells, K. Ryan, et al.
Publicado: (2020)

Plasma and Nail Zinc Concentrations, But Not Hair Zinc, Respond Positively to Two Different Forms of Preventive Zinc Supplementation in Young Laotian Children: a Randomized Controlled Trial
por: Wessells, K. Ryan, et al.
Publicado: (2020)

Hemoglobins F, A(2), and E levels in Laotian children aged 6‐23 months with Hb E disorders: Effect of age, sex, and thalassemia types
por: Kingchaiyaphum, Benchawan, et al.
Publicado: (2020)

Daily supplementation of a multiple micronutrient powder improves folate but not thiamine, riboflavin, or vitamin B(12) status among young Laotian children: a randomized controlled trial
por: Hinnouho, Guy-Marino, et al.
Publicado: (2022)

Effects of therapeutic zinc supplementation for diarrhea and two preventive zinc supplementation regimens on the incidence and duration of diarrhea and acute respiratory tract infections in rural Laotian children: A randomized controlled trial
por: Barffour, Maxwell A, et al.
Publicado: (2020)

Daily preventive zinc supplementation increases the antibody response against pathogenic Escherichia coli in children with zinc insufficiency: a randomised controlled trial
por: Kewcharoenwong, Chidchamai, et al.
Publicado: (2022)

Comparison of two forms of daily preventive zinc supplementation versus therapeutic zinc supplementation for diarrhea on young children’s physical growth and risk of infection: study design and rationale for a randomized controlled trial
por: Wessells, K. Ryan, et al.
Publicado: (2018)

Iron status and inherited haemoglobin disorders modify the effects of micronutrient powders on linear growth and morbidity among young Lao children in a double-blind randomised trial
por: Hess, Sonja Y., et al.
Publicado: (2019)

IGF-1 and IGFBP-3 in Inflammatory Cachexia
por: Martín, Ana Isabel, et al.
Publicado: (2021)

Serum IGF-1, IGFBP-3 and their ratio: Potential biochemical growth maturity indicators
por: Jain, Nimisha, et al.
Publicado: (2017)

Serum insulin-like growth factors (IGFs) and IGF binding protein (IGFBP)-3 in patients with gastric cancer: IGFBP-3 protease activity induced by surgery.
por: Lee, D. Y., et al.
Publicado: (1997)

Analysis of circulating insulin-like growth factor-1 (IGF-1) and IGF binding protein-3 (IGFBP-3) in tobacco smokers and non-smokers
por: Palmer, RM, et al.
Publicado: (2002)

Analysis of circulating insulin-like growth factor-1 (IGF-1) and IGF binding protein-3 (IGFBP-3) in tobacco smokers and non-smokers
por: Palmer, RM, et al.
Publicado: (2002)

Correlation between Salivary Levels of IGF-1, IGFBP-3, IGF-1/IGFBP3 Ratio with Skeletal Maturity Using Hand-Wrist Radiographs
por: Almalki, Abdullah, et al.
Publicado: (2022)

Cyclic glycine-proline regulates IGF-1 homeostasis by altering the binding of IGFBP-3 to IGF-1
por: Guan, Jian, et al.
Publicado: (2014)

Baseline IGFBP - 3 as the Key Element to Predict Growth Response to Growth Hormone and IGF - 1 Therapy in Subjects with Non - GH Deficient Short Stature and IGF - 1 Deficiency
por: Perez-Colon, Sheila, et al.
Publicado: (2018)

Associations among IGF-1, IGF2, IGF-1R, IGF-2R, IGFBP-3, insulin genetic polymorphisms and central precocious puberty in girls
por: Chang, Hua-Pin, et al.
Publicado: (2018)

Combined Evaluation of IGF−1 and IGFBP−3 as an Index of Efficacy and Safety in Growth Hormone Treated Patients
por: Şıklar, Zeynep, et al.
Publicado: (2009)

Intense Walking Exercise Affects Serum IGF-1 and IGFBP3
por: Kim, TaeHo, et al.
Publicado: (2015)

Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies
Publicado: (2010)

IGF-1, IGFBP-1, and IGFBP-3 Polymorphisms Predict Circulating IGF Levels but Not Breast Cancer Risk: Findings from the Breast and Prostate Cancer Cohort Consortium (BPC3)
por: Patel, Alpa V., et al.
Publicado: (2008)

Genetic variability in IGF-1 and IGFBP-3 and body size in early life
por: Poole, Elizabeth M, et al.
Publicado: (2012)

Analysis of the value and correlation of IGF-1 with GH and IGFBP-3 in the diagnosis of dwarfism
por: Wang, Yun, et al.
Publicado: (2019)

Evaluating the local expression pattern of IGF-1R in tumor tissues and the circulating levels of IGF-1, IGFBP-1, and IGFBP-3 in the blood of patients with different primary bone tumors
por: Vaezi, Mohammad Amin, et al.
Publicado: (2023)

Effects of Adenotonsillectomy on Serum Levels of IGF-1 and IGFBP-3 and Growth Indices in Children with Adenotonsillar Hypertrophy or Recurrent Tonsillitis
por: Farmarzi, Mohammad, et al.
Publicado: (2016)

Effects of recombinant human growth hormone in the treatment of dwarfism and relationship between IGF-1, IGFBP-3 and thyroid hormone
por: Ren, Shanxiang, et al.
Publicado: (2016)

Associations Between IGF1, IGFBP2 and TGFß3 Genes Polymorphisms and Growth Performance of Broiler Chicken Lines
por: Hosnedlova, Bozena, et al.
Publicado: (2020)

Gene Expression of IGF1, IGF1R, and IGFBP3 in Epiretinal Membranes of Patients with Proliferative Diabetic Retinopathy: Preliminary Study
por: Romaniuk, Dorota, et al.
Publicado: (2013)

Overlap of Peak Growth Activity and Peak IGF-1 to IGFBP Ratio: Delayed Increase of IGFBPs Versus IGF-1 in Serum as a Mechanism to Speed up and down Postnatal Weight Gain in Mice
por: Walz, Michael, et al.
Publicado: (2020)

IGF-1, IGF-2 and IGFBP-3 in prediagnostic serum: association with colorectal cancer in a cohort of Chinese men in Shanghai
por: Probst-Hensch, N M, et al.
Publicado: (2001)

Common genetic variation in IGF1, IGFBP-1, and IGFBP-3 in relation to mammographic density: a cross-sectional study
por: Tamimi, Rulla M, et al.
Publicado: (2007)

The associations of anthropometric, behavioural and sociodemographic factors with circulating concentrations of IGF‐I, IGF‐II, IGFBP‐1, IGFBP‐2 and IGFBP‐3 in a pooled analysis of 16,024 men from 22 studies
por: Watts, Eleanor L., et al.
Publicado: (2019)

IGFBP-3: So Much More Than an IGF1/2 Binding Protein
por: Marí, Montserrat
Publicado: (2020)

Assessment of compatibility of rhIGF-1/rhIGFBP-3 with neonatal intravenous medications
por: Salamat-Miller, Nazila, et al.
Publicado: (2022)

Effects of high-dose recombinant human growth hormone treatment on IGF-1 and IGFBP-3 levels in idiopathic dwarfism patients
por: Wu, Bin, et al.
Publicado: (2022)

Investigation of IGF1, IGF2BP2, and IGFBP3 variants with lymph node status and esophagogastric junction adenocarcinoma risk
por: Tang, Weifeng, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mklkeunti5gfr9l2jn9d07hhc1